Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
12/21/2000 | WO2000076511A1 Cyclopentyl modulators of chemokine receptor activity |
12/21/2000 | WO2000076510A1 Dermal anesthetic agents |
12/21/2000 | WO2000051987A3 Inhibitors of advanced, post-amadori glycosylation reactions |
12/21/2000 | WO2000044709A3 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS |
12/21/2000 | DE19927415A1 Indolinylharnstoffderivate Indolinylharnstoffderivate |
12/21/2000 | CA2412345A1 Antagonism of immunostimulatory cpg-oligonucleotides by 4-aminoquinolines and other weak bases |
12/21/2000 | CA2383008A1 Compounds |
12/21/2000 | CA2375920A1 Compounds |
12/21/2000 | CA2373394A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives |
12/21/2000 | CA2340663A1 Antiviral indoleoxoacetyl piperazine derivatives |
12/20/2000 | EP1061077A1 Novel pyridazine derivatives and drugs containing the same as the active ingredient |
12/20/2000 | EP1061074A1 Novel process and intermediates |
12/20/2000 | EP1061072A1 Pyrrolic compounds with a high herbicidal activity and their agronomic use |
12/20/2000 | EP1060749A1 Aqueous pharmaceutical composition comprising Tezosentan |
12/20/2000 | EP1060178A1 Heterocyclic compounds as inhibitors of rotamase enzymes |
12/20/2000 | EP1060175A2 Tryptase inhibitors |
12/20/2000 | EP1060173A2 Benzazine derivatives phosphodiesterase 4 inhibitors |
12/20/2000 | EP1060171A2 Tryptase inhibitors |
12/20/2000 | EP1060170A1 Optically active substituted 2,4-diamino-1,3,5-triazines as herbicides |
12/20/2000 | EP1060166A1 Five-membered, benzo-condensed heterocycles used as antithrombotic agents |
12/20/2000 | EP1060163A1 New piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides |
12/20/2000 | EP1059922A2 Glycine transport inhibitors |
12/20/2000 | EP0726898B1 Phenylindole compounds |
12/20/2000 | EP0543858B1 Benzimidazole derivatives, process for their preparation and application |
12/20/2000 | CN1277605A Arylpyridazinones as prostaglandin endoperoxide H synthase biosynthesis inhibitors |
12/20/2000 | CN1277604A Heteraryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors |
12/20/2000 | CN1277553A Neovascularization promoters and neovascularization potentiators |
12/20/2000 | CN1277194A New 1- aza-2-alkyl-6-aryl-cyclanes compound, its producing process and medical composition containing them |
12/19/2000 | US6162927 (2s,3r,4s)-2-(2,2-dimethylpentyl)-4-(7-methoxy-1,3-benzodioxol-5-yl)-1-(n,n-di(n-butyl)aminocarbonylmethyl)-pyrrolidine-3-carboxylic acid, or salt or ester thereof, in pure form; adminstering to treat hypertension, other diseases |
12/19/2000 | US6162918 Tetramethylacridinedione derivatives are inhibitors of herpes simplex virus thymidine kinase in the treatment and prophylaxis of infections caused by herpes simplex virus. |
12/19/2000 | US6162822 Bisimide compounds |
12/19/2000 | US6162816 Antisecretory, antiulcer agents |
12/19/2000 | US6162812 Pharmaceutical compositions containing HIV protease inhibitors and methods of their use |
12/19/2000 | US6162809 Pyridylthio compounds for controlling helicobacter bacteria |
12/19/2000 | US6162807 Thio acid derived monocyclic N-heterocyclics as anticoagulants |
12/19/2000 | US6162804 Tyrosine kinase inhibitors |
12/19/2000 | US6162800 N-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitors |
12/19/2000 | US6162442 Use of aqueous L-Tryptophan and/or L-Threonine salt solutions |
12/19/2000 | CA2001225C Antimicrobial lactam-quinolones |
12/18/2000 | CA2311872A1 Processes and intermediates for preparing (indole-2-carbonyl)-amides |
12/14/2000 | WO2000075135A1 Biaryl inhibitors of prenyl-protein transferase |
12/14/2000 | WO2000075134A1 Pyrazinone thrombin inhibitors |
12/14/2000 | WO2000075133A1 Novel isoquinoline derivatives or salts thereof |
12/14/2000 | WO2000075131A1 Substituted pyrazole compounds |
12/14/2000 | WO2000075130A1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
12/14/2000 | WO2000075119A2 Substituted 2-aryl-1,2,4-triazine-3,5-di(thi)ones used as herbicides |
12/14/2000 | WO2000075118A1 INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK) |
12/14/2000 | WO2000075117A1 Compositions and methods for inhibiting cell death |
12/14/2000 | WO2000075111A1 Formazan metal complex |
12/14/2000 | WO2000075108A1 Inhibitors of metalloproteinases |
12/14/2000 | WO2000075107A2 Bradykinin receptor antagonists |
12/14/2000 | WO2000074681A1 Metalloprotease inhibitors |
12/14/2000 | WO2000074679A1 Substituted piperidines as melanocortin-4 receptor agonists |
12/14/2000 | WO2000046187A3 Antizyme modulators and their use |
12/14/2000 | WO2000043032A3 Baff, inhibitors thereof and their use in the modulation of b-cell response |
12/14/2000 | CA2377369A1 Substituted piperidines as melanocortin-4 receptor agonists |
12/14/2000 | CA2375985A1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
12/14/2000 | CA2375942A1 Substituted 2-aryl-1,2,4-triazine-3,5-di(thi)ones |
12/14/2000 | CA2375882A1 Metalloprotease inhibitors |
12/14/2000 | CA2375843A1 Compositions and methods for inhibiting cell death |
12/14/2000 | CA2374460A1 Inhibitors of metalloproteinases |
12/13/2000 | EP1058698A1 Preparation for prevention and healing of inflammation affections |
12/13/2000 | EP1058684A1 Glycine transport inhibitors |
12/13/2000 | EP1058683A1 Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof |
12/13/2000 | EP1058680A1 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists |
12/13/2000 | EP1058549A1 THROMBIN OR FACTOR Xa INHIBITORS |
12/13/2000 | EP1058548A1 New use |
12/13/2000 | CN1276785A N-aroylphenylalanine derivs. |
12/13/2000 | CN1276370A Process for preparing anticancer compound, and intermediate |
12/13/2000 | CN1276211A Use of non-peptides NK3-antagonist |
12/12/2000 | US6160176 Anticoagulant agents |
12/12/2000 | US6160120 Optically pure 7-chloro-2-(2-(3-(1-(7-(1h-tetrazol-5-ylmethoxy) indol-1-yl)-4-(1h-tetrazol-5-yl) butyl)phenyl)ethenyl)quinoline |
12/12/2000 | US6160002 1-arylpyrazole derivatives; pesticides, parasiticides; veterinary medicine |
12/12/2000 | US6159995 Substituted diaminocarboxylic acids |
12/12/2000 | US6159990 Hypotensive agents for intraocular pressure; antiarrhythmia agents, benign prostate hyperplasia |
12/12/2000 | US6159984 Farnesyl protein transferase inhibitors |
12/12/2000 | US6159982 Treating psychological disorders, schizophrenia |
12/12/2000 | US6159980 Anxiolytic agents, antidepressants; psychological and eating disorders |
12/12/2000 | US6159979 Bicyclic aryl or a bicyclic heterocyclic ring containing compounds having a combined 5HT1A, 5HT1B and 5HT1D receptor antagonistic activity |
12/12/2000 | US6159974 LDL receptor gene expression promoters |
12/12/2000 | US6159964 Vitronectin receptor antagonists |
12/12/2000 | US6159941 Use of somatostatin agonists and antagonists for treating diseases related to the eye |
12/12/2000 | CA2160881C 10,11-methanodibenzosuberane derivatives used as chemosensitizing agents |
12/07/2000 | WO2000073299A1 Sulfonamide compounds with pharmaceutical activity |
12/07/2000 | WO2000073298A1 Mutual prodrugs of amlodipine and atorvastatin |
12/07/2000 | WO2000073284A2 1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors |
12/07/2000 | WO2000073283A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
12/07/2000 | WO2000073279A1 4-phenyl-pyrimidine derivatives |
12/07/2000 | WO2000073278A2 5-phenyl-pyrimidine derivatives |
12/07/2000 | WO2000073274A2 Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors |
12/07/2000 | WO2000073269A2 Nicotine receptor ligands |
12/07/2000 | WO2000072844A1 Neuronal death inhibitors |
12/07/2000 | WO2000072834A2 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property |
12/07/2000 | WO2000072801A2 Alpha v integrin receptor antagonists |
12/07/2000 | WO2000048584A3 Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain |
12/07/2000 | WO2000009104A3 Use of sulfonamides for treating vision and memory disorders |
12/07/2000 | DE19925593A1 Substituierte 2-Aryl-1,2,4-triazin-3,5-di(thi)one Substituted 2-aryl-1,2,4-triazine-3,5-di (thi) ones |
12/07/2000 | CA2376024A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
12/07/2000 | CA2375188A1 Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors |
12/07/2000 | CA2374921A1 Neuronal death inhibitors |